-+ 0.00%
-+ 0.00%
-+ 0.00%

PDS Biotech Raises Approximately $3.9 Million From NantWorks Warrant Exercise

PUBT·11/10/2026 13:04:25
Listen to the news
PDS Biotech Raises Approximately $3.9 Million From NantWorks Warrant Exercise
  • PDS Biotech raised approximately $3.9 million in gross proceeds from NantWorks' exercise of outstanding common stock warrants.
  • The exercise covered 17,699,115 common shares, or pre-funded warrants in lieu thereof, at $0.22 per share.
  • A nonwaivable 19.9% beneficial ownership limit required part of the exercise to be settled in pre-funded warrants.
  • Proceeds will support PDS0301's advancement toward a Phase 3 metastatic colorectal cancer trial, the PDS0101 partnership strategy and general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PDS Biotechnology Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100800PRIMZONEFULLFEED9874146) on November 10, 2026, and is solely responsible for the information contained therein.